Why the study?
Does the ERAS protocol decrease length of stay without increasing complications compared to TRAS in patients undergoing alloplastic breast reconstruction?
Does the ERAS protocol decrease length of stay without increasing complications compared to TRAS in patients undergoing alloplastic breast reconstruction?
The ERAS protocol for alloplastic breast reconstruction safely decreases length of stay without increasing complications.
ERAS may safely shorten stays in alloplastic breast reconstruction; hypothesis-generating and requires randomized confirmation.
The ERAS protocol for alloplastic breast reconstruction is safe, without increased readmission or complication rates compared to TRAS, and significantly decreased length of stay.
No takes yet. Share an insight, caveat, or question.
Dumestre et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: